JPH08502489A - ミクロスフィアおよびモノクローナル抗体を用いた骨髄からの腫瘍細胞の免疫学的パージング - Google Patents

ミクロスフィアおよびモノクローナル抗体を用いた骨髄からの腫瘍細胞の免疫学的パージング

Info

Publication number
JPH08502489A
JPH08502489A JP6510304A JP51030494A JPH08502489A JP H08502489 A JPH08502489 A JP H08502489A JP 6510304 A JP6510304 A JP 6510304A JP 51030494 A JP51030494 A JP 51030494A JP H08502489 A JPH08502489 A JP H08502489A
Authority
JP
Japan
Prior art keywords
bone marrow
cells
monoclonal antibody
tumor cells
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP6510304A
Other languages
English (en)
Japanese (ja)
Inventor
スチュアート エフ シュロッスマン
リー エム ネドラー
アーノルド エス フリードマン
Original Assignee
ダナ−ファーバー キャンサー インスティチュート
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ダナ−ファーバー キャンサー インスティチュート filed Critical ダナ−ファーバー キャンサー インスティチュート
Publication of JPH08502489A publication Critical patent/JPH08502489A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3061—Blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
JP6510304A 1992-10-19 1993-10-18 ミクロスフィアおよびモノクローナル抗体を用いた骨髄からの腫瘍細胞の免疫学的パージング Pending JPH08502489A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96310492A 1992-10-19 1992-10-19
US07/963,104 1992-10-19
PCT/US1993/009891 WO1994008621A1 (fr) 1992-10-19 1993-10-18 Purge immunologique de cellules tumorales de la moelle osseuse a l'aide de microspheres et d'anticorps monoclonaux

Publications (1)

Publication Number Publication Date
JPH08502489A true JPH08502489A (ja) 1996-03-19

Family

ID=25506759

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6510304A Pending JPH08502489A (ja) 1992-10-19 1993-10-18 ミクロスフィアおよびモノクローナル抗体を用いた骨髄からの腫瘍細胞の免疫学的パージング

Country Status (5)

Country Link
EP (1) EP0671950A4 (fr)
JP (1) JPH08502489A (fr)
AU (1) AU681605B2 (fr)
CA (1) CA2147010A1 (fr)
WO (1) WO1994008621A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100124741A1 (en) * 2008-11-18 2010-05-20 Quest Disgnostics Investments Incorporated METHODS FOR DETECTING IgH/BCL-1 CHROMOSOMAL TRANSLOCATION
EP3527659A1 (fr) * 2018-02-14 2019-08-21 Universidad del Pais Vasco Procédé d'obtention d'une population cellulaire de spermatozoïdes à aptitudes améliorées

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4692405A (en) * 1985-03-05 1987-09-08 Dana-Farber Cancer Institute, Inc. Monoclonal antibodies to antigen on activated human B-cells and assay therefor, protein antigenic determinant therefor and method of making same
WO1990010692A1 (fr) * 1989-03-15 1990-09-20 University Of Florida Anticorps monoclonal utilise pour la detection et le traitement de la leucemie infantile

Also Published As

Publication number Publication date
CA2147010A1 (fr) 1994-04-28
AU681605B2 (en) 1997-09-04
EP0671950A4 (fr) 1996-07-31
AU5361694A (en) 1994-05-09
WO1994008621A1 (fr) 1994-04-28
EP0671950A1 (fr) 1995-09-20

Similar Documents

Publication Publication Date Title
Epstein et al. Biology of the human malignant lymphomas. IV. Functional characterization of ten diffuse histiocytic lymphoma cell lines
Myers et al. Lymphomatoid granulomatosis
Parry et al. NK cell function is markedly impaired in patients with chronic lymphocytic leukaemia but is preserved in patients with small lymphocytic lymphoma
Gribben et al. Bone marrows of non-Hodgkin's lymphoma patients with a bcl-2 translocation can be purged of polymerase chain reaction-detectable lymphoma cells using monoclonal antibodies and immunomagnetic bead depletion
US7049072B2 (en) Gene expression analysis of pluri-differentiated mesenchymal progenitor cells and methods for diagnosing a leukemic disease state
Dietrich et al. Second primary cancers in patients continuously disease-free from Hodgkin's disease: a protective role for the spleen?
Johnson et al. Detection of cells bearing the t (14; 18) translocation following myeloablative treatment and autologous bone marrow transplantation for follicular lymphoma.
Leung et al. Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing’s sarcoma
Berinstein et al. Detection of occult lymphoma in the peripheral blood and bone marrow of patients with untreated early-stage and advanced-stage follicular lymphoma.
KR20140039318A (ko) 펩티드 암 항원 특이적 ｔ 세포의 리셉터 유전자
Winter et al. Low-grade lymphoma
Fischer et al. Characterization of the autoreactive T cell repertoire in cyclosporin-induced syngeneic graft-versus-host disease. A highly conserved repertoire mediates autoaggression.
US7273753B2 (en) Purification and uses of dendritic cells and monocytes
Tarella et al. Negative immunomagnetic ex vivo purging combined with high-dose chemotherapy with peripheral blood progenitor cell autograft in follicular lymphoma patients: evidence for long-term clinical and molecular remissions
Wörmann Implications of detection of minimal residual disease
Combaret et al. Immunomagnetic depletion of malignant cells from autologous bone marrow graft: from experimental models to clinical trials
JPH08502489A (ja) ミクロスフィアおよびモノクローナル抗体を用いた骨髄からの腫瘍細胞の免疫学的パージング
Mizuta et al. Accurate quantitation of residual tumor burden at bone marrow harvest predicts timing of subsequent relapse in patients with common ALL treated by autologous bone marrow transplantation
Kimlinger et al. Expression of the hematopoietic stem cell antigen CD34 on blood and bone marrow monoclonal plasma cells from patients with multiple myeloma
Cooksey et al. Natural killer cells in renal allograft rejection
Kojima et al. Occurrence of monocytoid B-cells in reactive lymph node lesions
Davey et al. Studies of lymphocyte proliferation in hairy cell leukaemia: activity in mixed lymphocyte reaction and responses to mitogens
Holmgren et al. Allogeneic inhibition between two human cell lines
Vescio et al. Characterization of the Myeloma Clone
Viciana et al. Simultaneous expression of CD2 on a B‐cell, small lymphocytic neoplasm